
Biomark Capital
North America, Connecticut, United States, Greenwich
Description
Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies.
Investor Profile
Biomark Capital has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 8% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Series A rounds (top funding stages).
- Majority of deals are located in United States, Taiwan.
- Strong thematic focus on Medical, Health Care, Biotechnology.
Stage Focus
- Series Unknown (58%)
- Post Ipo Equity (8%)
- Series A (8%)
- Series B (8%)
- Seed (8%)
- Series E (8%)
Country Focus
- United States (83%)
- Taiwan (17%)
Industry Focus
- Medical
- Health Care
- Biotechnology
- Pharmaceutical
- Health Diagnostics
- Biopharma
- Medical Device
- Manufacturing
- Information Technology
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Biomark Capital frequently co-invest with?
Which angels does Biomark Capital often collaborate with?
What are some of recent deals done by Biomark Capital?
Find More Investors Like Biomark Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides











